Literature DB >> 12366609

Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases.

Y Izumi1, A Kaneko, K Oku, M Kimura, S Tanaka, H Tada, K Tatsumi, T Takano, Y Hidaka, N Amino.   

Abstract

Autoimmune diseases, especially autoimmune thyroid disease, frequently develop after delivery due to the immune rebound mechanism. Most cases involve transient dysfunction of affected organs. We examined three patients who developed liver dysfunction after delivery. They were all diagnosed with definite or probable autoimmune hepatitis using the scoring system of the International Autoimmune Hepatitis Group. Moreover, all of them had anti-CYP2D6 antibodies detected by a sensitive radioligand assay. Our findings strongly suggest that liver dysfunction is induced by postpartum autoimmune hepatitis, and clinicians should be aware of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12366609     DOI: 10.1046/j.1365-2796.2002.01047.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  4 in total

Review 1.  Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis.

Authors:  Kazuo Ohba; Katsuhisa Omagari; Chika Kusakari; Yoshiko Kadokawa; Kenji Hayashida; Fuminao Takeshima; Yohei Mizuta; Ikuo Murata; Yasuni Nakanuma; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 2.  Sex-related factors in autoimmune liver diseases.

Authors:  Dorothee Schwinge; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

Review 3.  T helper cell immunity in pregnancy and influence on autoimmune disease progression.

Authors:  Jonathon J Graham; Maria Serena Longhi; Michael A Heneghan
Journal:  J Autoimmun       Date:  2021-05-18       Impact factor: 7.094

4.  Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"

Authors:  Pier Leopoldo Capecchi; Pietro Enea Lazzerini; Stefano Brillanti
Journal:  J Hepatol       Date:  2021-05-05       Impact factor: 25.083

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.